Drug Prices Potentially to Change Under Trump Administration

Trump Adds a Global Pricing Plan to Wide Attack on Drug Prices, But Doubts Persist
– Kaiser Health News

Manatt’s Ian Spatz, a senior advisor with our Manatt Health team, spoke with Kaiser Health News for an article on the Trump administration’s blueprint to upend the healthcare industry.

The publication noted that President Donald Trump revealed his blueprint to change expensive drug prices through proposals that would require television ads to disclose drug prices, would change rebates between drug makers and industry middlemen, and more.

Spatz said that the blueprint was “unprecedented in terms of how many different ideas and areas of ideas that it contained.”

Read the article here



pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved